Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement

Purpose: Topical corticosteroids used to treat ocular inflammation are associated with a high risk of clinically significant toxicities. Therefore, corticosteroid-sparing medications to treat ocular inflammation are needed. Noninfectious anterior uveitis (NAU) is a sight-threatening ocular inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandell, Kenneth J., Clark, David, Chu, David S., Foster, C. Stephen, Sheppard, John, Brady, Todd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757619/
https://www.ncbi.nlm.nih.gov/pubmed/32955967
http://dx.doi.org/10.1089/jop.2020.0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757619/
https://www.ncbi.nlm.nih.gov/pubmed/32955967
http://dx.doi.org/10.1089/jop.2020.0056

Ejemplares similares